Argenica Therapeutics Doses First Batch of Patients for Phase Two Stroke Trial
Argenica Therapeutics Doses First Batch of Patients for Phase Two Stroke Trial
Argenica Therapeutics 爲第二階段中風試驗的第一批患者服藥
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊